IPH LIMITED (IPH)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IPH

IPH - IPH LIMITED

FNArena Sector : Legal
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.55
Index: ASX200 | ASX300 | ALL-ORDS

IPH Ltd is Australia's largest intellectual property services company providing protection, commercialisation and management of intellectual property. It has been a listed company since 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.94

20 Feb
2025

0.150

OPEN

$4.86

3.13%

HIGH

$5.09

2,427,249

LOW

$4.57

TARGET
$6.49

-0.40 change from previous day

 31.4% upside
Franking for last dividend paid out: 35%
OTHER COMPANIES IN THE SAME SECTOR
SHJ .
FNARENA'S MARKET CONSENSUS FORECASTS
IPH: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 25.1 46.1 xxx
DPS (cps) xxx 35.0 35.0 xxx
EPS Growth xxx - 12.4% 83.7% xxx
DPS Growth xxx 6.1% 0.0% xxx
PE Ratio xxx N/A 10.6 xxx
Dividend Yield xxx N/A 7.2% xxx
Div Pay Ratio(%) xxx 139.6% 76.0% xxx

Dividend yield today if purchased 3 years ago: 4.22%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 7.17

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/02 - ex-div 16c (franking 35%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx25.1
DPS All xxxxxxxxxxxxxxx35.0
Sales/Revenue xxxxxxxxxxxxxxx605.6 M
Book Value Per Share xxxxxxxxxxxxxxx257.4
Net Operating Cash Flow xxxxxxxxxxxxxxx131.9 M
Net Profit Margin xxxxxxxxxxxxxxx10.04 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx10.04 %
Return on Invested Capital xxxxxxxxxxxxxxx5.72 %
Return on Assets xxxxxxxxxxxxxxx4.84 %
Return on Equity xxxxxxxxxxxxxxx10.04 %
Return on Total Capital xxxxxxxxxxxxxxx11.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx64.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx10 M
Long Term Debt xxxxxxxxxxxxxxx482 M
Total Debt xxxxxxxxxxxxxxx492 M
Goodwill - Gross xxxxxxxxxxxxxxx594 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx76 M
Price To Book Value xxxxxxxxxxxxxxx2.44

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx11.0 M
Capex % of Sales xxxxxxxxxxxxxxx1.82 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx413 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

21/02/2025

1

Buy

$6.00

21.46%

IPH Ltd reported 1H25 EBITDA in line with consensus, though like-for-like earnings declined -3% year-on-year due to higher corporate costs.

UBS analysts have maintained a Buy rating on IPH, lowering the price target to $6.80 from $7.90. Financial forecasts have been revised, with a -14% cut to the valuation due to reduced long-term earnings expectations and a lower forward PE multiple.

Management highlighted early signs of recovery in Asia, with revenue growth expected in 2H25, though weak US patent filings remain a headwind.

The broker sees IPH as undervalued given its strong cash generation and market leadership but notes that an organic growth turnaround is needed for a re-rating.

FORECAST
UBS forecasts a full year FY25 EPS of 46.00 cents.
UBS forecasts a full year FY26 EPS of 49.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Petra Capital

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

28/01/2025

0

Cessation of coverage

Goldman Sachs suspends coverage of IPH following a reallocation of research coverage between analysts at the broker.

Jarden

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Extra Coverage Research History >

IPH STOCK CHART

FNArena News on IPH

1
FNArena Corporate Results Monitor – 22-02-2025

2:00 PM - Australia
2
Rudi’s View: Best Buys & Convictions For 2025

Jan 16 2025 - Rudi's View
3
Rudi’s View: Final Best Buys & Conviction Ideas

Dec 23 2024 - Rudi's View
4
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
5
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View

Latest Legal News

1
IPH Ready For Further Expansion

Oct 11 2022 - Small Caps
2
IPH Ltd’s Growth Plans Undaunted

Sep 08 2020 - Australia
3
Treasure Chest: Class Actions Entice Shine Corporate

Mar 27 2019 - Treasure Chest
4
Confidence Grows In IPH

Aug 20 2018 - Australia
5
Brokers Take Knife To Xenith IP

Oct 16 2017 - Small Caps
6
IPH Expands NZ Presence

Oct 12 2017 - Small Caps
7
Wait For Buying Opportunity In JB Hi-Fi

Oct 11 2016 - Technicals
8
Growth Opportunities Abound For Xenith

Sep 01 2016 - Small Caps
9
IPH Advancing On Acquisition Targets

Aug 22 2016 - Australia
10
Opportunity In IPH

Jun 14 2016 - Technicals